Mergermarket Recognizes Dechert as Top Law Firm for Life Sciences & Healthcare M&A Deals in 1H 2015
Dechert was ranked among the top law firms for both total value and total volume of U.S. M&A deals in the Life Sciences & Healthcare sector in 1H 2015 according to Mergermarket. Dechert was also ranked among the top five law firms for total volume of pan-European deals in the Pharma, Medical & Biotech sector in 1H 2015. This recognition was included in the half-year editions of Deal Drivers EMEA and Deal Drivers Americas, published by Mergermarket in association with Merrill DataSite. These reports provide an in-depth review of M&A activity for the half-year of 2015, offering key insights into how announced deals will impact M&A for the remainder of the year.
"Dechert has been particularly active in U.S.-centric and cross-border life sciences M&A and Collaboration transactions this year," said David Schulman, co-chair of the firm's life sciences group. "Dechert’s work in this sector is a priority for the firm, and with our team of life sciences lawyers spread across the U.S., Europe and Asia, we have been fortunate enough to have been involved in a number of high-profile deals for pharmaceutical and biotech companies, drug distributors and venture capitalists.”
Life science M&A highlights from the first half of 2015 include representing our client Celgene Corporation, a global biopharmaceutical company, in two major transactions – the acquisition of a 10% stake in Juno Therapeutics, Inc. as part of a ten-year collaboration for the development and commercialization of immunotherapies worth approximately US$1 billion, as well as Celgene’s US$485 million acquisition of Quanticel Pharmaceuticals, Inc., a privately held biotechnology company focused on cancer drug discovery. We also advised long-time client MWI Veterinary Supply, Inc., the leading animal health distribution company in the United States, on its sale to AmerisourceBergen Corporation for US$2.5 billion. Dechert attorneys also provided antitrust and regulatory counsel to CVS Health in connection with its US$12.7 billion purchase of pharmacy services giant Omnicare Inc.
Other life science M&A highlights from 1H 2015 include:
About Dechert
Dechert is a global specialist law firm focused on sectors with the greatest complexities and highest regulatory demands. We deliver practical commercial insight and judgment to our clients’ most important matters. Nothing stands in the way of giving clients the best of the firm’s entrepreneurial energy and seamless collaboration in a way that is distinctively Dechert.
